Benzinga | Oct 13, 2021 01:38PM EDT

Trevena Announces Two OLINVYK Presentations At ANESTHESIOLOGY 2021

Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced two presentations at ANESTHESIOLOGY(r) 2021, the national conference for the American Society of Anesthesiologists (ASA). Both posters highlighted safety data from the OLINVYK (oliceridine) injection program. The meeting was held on October 8th to 12th in San Diego, California.



"I am pleased that we continue to expand the published database underlying OLINVYK's compelling product profile," said Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer of Trevena. "The robust data that we have generated in clinically complex patients will continue to serve as valuable information for healthcare providers as they consider the use of OLINVYK in their post-operative patients."